BOTHELL, Wash.--(BUSINESS WIRE)--Seattle Genetics, Inc. (Nasdaq: SGEN) today announced that Chris Boerner, Ph.D. has been promoted to Senior Vice President, Commercial. Dr. Boerner joined Seattle Genetics in November 2010 as Vice President, Marketing, and has served as a key member of the commercial organization involved in the launch of ADCETRIS™ (brentuximab vedotin). He replaces Bruce Seeley, former Executive Vice President, Commercial, who is leaving Seattle Genetics to pursue other opportunities.
